Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Research gaps and future needs for allergen prediction in food safety

  • Fernández-Dumont, Antonio
  • Danisman, Ece
  • Taheri Boroujerdi, M.
  • Kazemi, Sahar
  • Moreno, F. Javier
  • Epstein, Michelle M.
The allergenicity and protein risk assessments in food safety are facing new challenges. Demands for healthier and more sustainable food systems have led to significant advances in biotechnology, the development of more complex foods, and the search for alternative protein sources. All this has increased the pressure on the safety assessment prediction approaches anchored into requirements defined in the late 90's. In 2022, the EFSA's Panel on Genetically Modified Organisms published a scientific opinion focusing on the developments needed for allergenicity and protein safety assessments of new products derived from biotechnology. Here, we further elaborate on the main elements described in this scientific opinion and prioritize those development needs requiring critical attention. The starting point of any new recommendation would require a focus on clinical relevance and the development of a fit-for-purpose database targeted for specific risk assessment goals. Furthermore, it is imperative to review and clarify the main purpose of the allergenicity risk assessment. An internationally agreed consensus on the overall purpose of allergenicity risk assessment will accelerate the development of fit-for-purpose methodologies, where the role of exposure should be better clarified. Considering the experience gained over the last 25 years and recent scientific developments in the fields of biotechnology, allergy, and risk assessment, it is time to revise and improve the allergenicity safety assessment to ensure the reliability of allergenicity assessments for food of the future., The authors acknowledge funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 965173 (Imptox) and European Union's Horizon Europe research and innovation programme under the Marie Skłodowska-Curie grant agreement No 101072377., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

An integrated approach to assess exposure and early health effects in human populations exposed to micro- and nanoplastics

  • Catalán, Julia
  • Afanou, Anani K.
  • Arranz, Jéssica Arribas
  • Riaza, Arantxa Ballesteros
  • Banic, Ivana
  • Dirven, Hubert
  • Estrela-Lopis, Irina
  • Hernández, Alba
  • Kanerva, Tomi
  • Laforsch, Christian
  • Lenssen, Esther
  • Löder, Martin G.J.
  • Pastor, Susana
  • Pulli, Hanna
  • Ramsperger, Anja F.R.M.
  • Snapkow, Igor
  • Turkalj, Mirjana
  • Vela, Verónica
  • Venus, Tom
  • Zou, Runyu
  • Bergamaschi, Enrico
Although cumulative evidence from in vitro and in vivo studies indicates that micro- and nanoplastics (MNPs) can induce toxic effects, and MNPs have been detected in several human fluids and tissues, the consequences of MNP exposure to human health still remain unknown. Human biomonitoring (HBM) studies allow assessing human exposure to MPs and associated adverse health effects, contributing to the risk assessment of these environmental pollutants. To date, reliable human exposure estimates are hindered by the lack of standardized processing and analytical methods to detect MNPs in human tissues, and limited evidence on the MNP-related adverse health effects exists. Occupational environments, where plastics are processed, may represent prioritized settings for such evaluations, as workers typically face higher exposure levels than the general population. Population sub-groups with potentially higher susceptibility, such as children and pregnant women, should also be considered. To develop effective preventive strategies, it is essential to identify and validate sensitive and specific biomarkers of exposure and early biological changes, which could result in adverse health effects. Standardized protocols integrating environmental exposure assessment with HBM, and sensitive methods for evaluating internal dose resulting from cumulative exposure to MNP particles and associated chemicals are needed. Based on the experience gathered by a multidisciplinary panel of experts belonging to the European Research Cluster to Understand the Health Impacts of MNPs (CUSP), this consensus paper describes the key elements that should be part of an integrated HBM approach for MNP exposure, emphasizing existing challenges and proposing solutions for future studies.